Your browser doesn't support javascript.
loading
Therapeutic antibody glycosylation impacts antigen recognition and immunogenicity.
Wolf, Babette; Piksa, Mateusz; Beley, Isabelle; Patoux, Agnes; Besson, Thierry; Cordier, Valerie; Voedisch, Bernd; Schindler, Patrick; Stöllner, Daniela; Perrot, Ludovic; von Gunten, Stephan; Brees, Dominique; Kammüller, Michael.
Afiliação
  • Wolf B; Novartis Institutes for BioMedical Research, Basel, Switzerland.
  • Piksa M; Novartis Institutes for BioMedical Research, Basel, Switzerland.
  • Beley I; Novartis Institutes for BioMedical Research, Basel, Switzerland.
  • Patoux A; Novartis Institutes for BioMedical Research, Basel, Switzerland.
  • Besson T; Novartis Institutes for BioMedical Research, Basel, Switzerland.
  • Cordier V; Novartis Institutes for BioMedical Research, Basel, Switzerland.
  • Voedisch B; Novartis Institutes for BioMedical Research, Basel, Switzerland.
  • Schindler P; Novartis Institutes for BioMedical Research, Basel, Switzerland.
  • Stöllner D; Novartis Institutes for BioMedical Research, Basel, Switzerland.
  • Perrot L; Novartis Institutes for BioMedical Research, Basel, Switzerland.
  • von Gunten S; Institute of Pharmacology, University of Bern, Bern, Switzerland.
  • Brees D; Novartis Institutes for BioMedical Research, Basel, Switzerland.
  • Kammüller M; Novartis Institutes for BioMedical Research, Basel, Switzerland.
Immunology ; 166(3): 380-407, 2022 07.
Article em En | MEDLINE | ID: mdl-35416297

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ativação Linfocitária / Apresentação de Antígeno Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ativação Linfocitária / Apresentação de Antígeno Idioma: En Ano de publicação: 2022 Tipo de documento: Article